Veterans Affairs Canada (VAC) is mulling putting disposable cannabis vape pens on the list of drugs and devices that qualify for a reimbursement program.

The department has categorized vaporizers as medical devices for about five years. Veterans, as well as retired RCMP officers, may be reimbursed up to $300 for their purchase of a vape to be used with doctor-prescribed medical cannabis.

Canopy Growth Corp. said Friday the company plans to delay the launch of its cannabis-infused drinks as the pot giant takes more time to complete the build-out of its bottling facility for commercial production.

Canopy didn’t specify when it plans to make its various pot-infused beverages available for sale. It previously stated it would have its drinks on store shelves in early January. The company said in a statement Friday that it does not believe the delay will have a material impact on its revenue for its 2020 financial year, which ends in March, and will provide an update when it releases its third-quarter results on Feb. 14.

Canopy submitted its final documentation for its beverage facility to Health Canada last June and received its licence in late November.

Read entire article here.

Although Canada’s recreational cannabis market failed to exceed expectations in 2019, the market faced significant headwinds, and this is a trend that seems to be abating.

We believe that two main factors will play a key role in how the Canadian cannabis retail market grows from here. These factors are related to the number of open dispensaries and the types of products that are allowed to be sold. In late 2019, the edibles and vape pens were legalized in Canada and we are bullish on the growth prospects associated with this vertical.

Some of Canada's biggest cannabis producers are facing proposed class-action lawsuits in the United States after investors were hit with steep financial losses in the stock market.

At least nine U.S. law firms are pursuing cases against Canopy Growth, Aurora Cannabis and Hexo Corp. in American courts.

Although the allegations vary, each pot producer is accused of misleading investors or failing to disclose certain problems with their businesses. When those problems became publicly known, the lawsuits claim, share prices plunged and investors were stuck with losses.

"[Investors] are mad; they were taken by surprise," said Reed Kathrein, a lawyer at Hagens Berman Sobol Shapiro LLP, which is pursuing claims against all three producers.

Cannabis stocks are facing a year in which they will finally have to put their money where their mouths are. Investors will need to see profitability from the full range of product types, and they will need to see it even before the retail environment is optimized.

While there is some bullishness that a relaxing of the retail stranglehold on cannabis sales will boost top lines this year, patience is wearing thin.

In 1972, 20 women were placed in two groups in isolation in a downtown hospital. Ten of the participants were instructed to smoke cannabis every night over the course of 98 days, with increasing THC potency over time. The other 10 study participants remained sober. All were given tasks to focus on during the day — like making braided macrame belts and wall hangings —while researchers observed their behaviour. The goal of the Ontario government-funded study, dubbed Project Venus, was to find out if cannabis affected productivity. 

Read entire article here.

Although Canada’s recreational cannabis market failed to exceed expectations in 2019, the market faced significant headwinds, and this is a trend that seems to be abating.

We believe that two main factors will play a key role in how the Canadian cannabis retail market grows from here. These factors are related to the number of open dispensaries and the types of products that are allowed to be sold. In late 2019, the edibles and vape pens were legalized in Canada and we are bullish on the growth prospects associated with this vertical.

s the first G7 country to legalize cannabis, Canada is becoming a point of reference for the global cannabis industry on production, distribution and retail models. The rest of the world is watching closely. However, far more educating about cannabis needs to be done. Consumers still don’t know enough about cannabis, the laws that govern it, and how to use it safely. Cannabis education is urgently needed, and is critical to the growth of the industry here and abroad.

Thanks to changes in WADA policies, Olympic athletes can use CBD legally for the first time.

A new champion will be crowned when the 2020 Summer Olympics debut in Tokyo. We’re not talking gold medals or world records, though. Instead, a new presence will be felt for the first time legally at the Olympics—cannabidiol, or CBD.

The World Anti-Doping Agency, an organization that monitors and fights against the use of drugs in the Olympics, announced in 2018 that CBD had been removed from its list of banned substances. Since the organization’s formation in 1999, all cannabinoids like CBD and THC had been banned for all Olympic athletes. The 2020 Olympics represents the first games in which athletes can legally use CBD without fear of consequence.